These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 5467968)
1. Efficacy of intradermally administered A2 Hong Kong vaccine. Foy HM; Sealey L; Cooney MK; Bor E JAMA; 1970 Jul; 213(1):130. PubMed ID: 5467968 [No Abstract] [Full Text] [Related]
2. Effect of dosage and route of inoculation upon antigenicity of inactivated influenza virus vaccine (Hong Kong strain) in man. Tauraso NM; Gleckman R; Pedreira FA; Sabbaj J; Yahwak R; Madoff MA Bull World Health Organ; 1969; 41(3):507-16. PubMed ID: 5309465 [TBL] [Abstract][Full Text] [Related]
3. Response to intradermal vaccination with A2, Hong Kong variant, influenza vaccine. McElroy JT; Szwed JJ N Engl J Med; 1969 Nov; 281(19):1076. PubMed ID: 5343531 [No Abstract] [Full Text] [Related]
4. Topical imiquimod before intradermal trivalent influenza vaccine for protection against heterologous non-vaccine and antigenically drifted viruses: a single-centre, double-blind, randomised, controlled phase 2b/3 trial. Hung IF; Zhang AJ; To KK; Chan JF; Li P; Wong TL; Zhang R; Chan TC; Chan BC; Wai HH; Chan LW; Fong HP; Hui RK; Kong KL; Leung AC; Ngan AH; Tsang LW; Yeung AP; Yiu GC; Yung W; Lau JY; Chen H; Chan KH; Yuen KY Lancet Infect Dis; 2016 Feb; 16(2):209-18. PubMed ID: 26559482 [TBL] [Abstract][Full Text] [Related]
5. Development of antibodies to neuraminidase of A2-Hong Kong and A2-Taiwan influenza viruses after administration of different Hong Kong vaccines and after natural infection in humans. Závadová H Acta Virol; 1973 Jul; 17(4):287-92. PubMed ID: 4148207 [No Abstract] [Full Text] [Related]
6. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children. Hosai H; Omura S; Maeda A; Kunita N Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350 [No Abstract] [Full Text] [Related]
7. Antibody responses in serum and nasal secretions according to age of recipient and method of administration of A2-Hong Kong-68 inactivated influenza virus vaccine. Fulk RV; Fedson DS; Huber MA; Fitzpatrick JR; Kasel JA J Immunol; 1970 Jan; 104(1):8-13. PubMed ID: 4983534 [No Abstract] [Full Text] [Related]
8. Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines. Vankerckhoven V; Van Damme P Expert Opin Drug Deliv; 2010 Sep; 7(9):1109-25. PubMed ID: 20716021 [TBL] [Abstract][Full Text] [Related]
9. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine. Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093 [No Abstract] [Full Text] [Related]
10. Intradermal influenza immunization. Experience with Hong Kong vaccine. Marks MI; Eller JJ Am Rev Respir Dis; 1971 Apr; 103(4):579-81. PubMed ID: 5550353 [No Abstract] [Full Text] [Related]
12. [Antibody response to anti-influenza vaccination with A2-Hong Kong-68 and B-Roma-1-67 bivalent vaccine]. Dal Fabbro G; Valletta G; Frugoni G; Ricciardi-Tenore N Minerva Med; 1972; 63(38):2167-71. PubMed ID: 4664783 [No Abstract] [Full Text] [Related]
13. Cost-effectiveness of an influenza vaccination program offering intramuscular and intradermal vaccines versus intramuscular vaccine alone for elderly. Leung MK; You JH Vaccine; 2016 May; 34(22):2469-76. PubMed ID: 27079928 [TBL] [Abstract][Full Text] [Related]
14. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity. Gwaltney JM; Edmondson WP; Rothenberg R; White PW Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719 [No Abstract] [Full Text] [Related]
15. Haemagglutination-inhibiting antibody response to and efficacy of inactivated Hong Kong influenza vaccine. Sonoguchi T Bull World Health Organ; 1969; 41(3):517-23. PubMed ID: 5309466 [TBL] [Abstract][Full Text] [Related]
16. [Prevention of influenza by vaccines administered intramuscularly and intradermally]. Trivello R; Gasparini V; Moschen ME; Romano M; Farisano G; Manicardi GC Ann Sclavo; 1972; 14(6):705-15. PubMed ID: 4130435 [No Abstract] [Full Text] [Related]
17. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. Holland D; Booy R; De Looze F; Eizenberg P; McDonald J; Karrasch J; McKeirnan M; Salem H; Mills G; Reid J; Weber F; Saville M J Infect Dis; 2008 Sep; 198(5):650-8. PubMed ID: 18652550 [TBL] [Abstract][Full Text] [Related]